Morning Read: Renowned neurologist and author Oliver Sacks dies, Amicus acquires Scioderm in a $229M deal
Renowned neurologist and author Oliver Sacks has died of cancer at the age of 82, Amicus Therapeutics has acquired a drug to treat a rare skin disorder through its purchase of Scioderm in a $229 million deal.